Northern Trust’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.2K | Hold |
53,609
| – | – | ﹤0.01% | 4353 |
|
2025
Q1 | $15.3K | Hold |
53,609
| – | – | ﹤0.01% | 4364 |
|
2024
Q4 | $31.5K | Hold |
53,609
| – | – | ﹤0.01% | 4330 |
|
2024
Q3 | $23.9K | Hold |
53,609
| – | – | ﹤0.01% | 4319 |
|
2024
Q2 | $142K | Buy |
53,609
+389
| +0.7% | +$1.03K | ﹤0.01% | 3961 |
|
2024
Q1 | $146K | Sell |
53,220
-1,040
| -2% | -$2.85K | ﹤0.01% | 3982 |
|
2023
Q4 | $132K | Sell |
54,260
-258
| -0.5% | -$627 | ﹤0.01% | 4041 |
|
2023
Q3 | $110K | Sell |
54,518
-2,900
| -5% | -$5.86K | ﹤0.01% | 3989 |
|
2023
Q2 | $169K | Sell |
57,418
-223,221
| -80% | -$659K | ﹤0.01% | 3888 |
|
2023
Q1 | $702K | Buy |
280,639
+5,987
| +2% | +$15K | ﹤0.01% | 3332 |
|
2022
Q4 | $871K | Sell |
274,652
-1,641
| -0.6% | -$5.2K | ﹤0.01% | 3313 |
|
2022
Q3 | $820K | Sell |
276,293
-3,751
| -1% | -$11.1K | ﹤0.01% | 3359 |
|
2022
Q2 | $855K | Buy |
280,044
+3,672
| +1% | +$11.2K | ﹤0.01% | 3379 |
|
2022
Q1 | $3.73M | Sell |
276,372
-12,315
| -4% | -$166K | ﹤0.01% | 2752 |
|
2021
Q4 | $3.76M | Sell |
288,687
-385
| -0.1% | -$5.02K | ﹤0.01% | 2869 |
|
2021
Q3 | $2.71M | Buy |
289,072
+188,287
| +187% | +$1.77M | ﹤0.01% | 3118 |
|
2021
Q2 | $1.03M | Sell |
100,785
-51,800
| -34% | -$530K | ﹤0.01% | 3517 |
|
2021
Q1 | $2.81M | Buy |
152,585
+7,278
| +5% | +$134K | ﹤0.01% | 3073 |
|
2020
Q4 | $4.98M | Buy |
+145,307
| New | +$4.98M | ﹤0.01% | 2688 |
|